Related Experiment Video
Updated: Apr 17, 2026

04:56
Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
665
Aortic disease: thoracic endovascular aortic repair
Colin Bicknell1, Janet T Powell2
1Department of Surgery & Cancer, Imperial College London, St Mary's Hospital, London, UK.
Heart (British Cardiac Society)
|February 14, 2015
Summary
Thoracic endovascular aortic repair (TEVAR) has advanced rapidly since 1987, offering benefits for acute thoracic conditions. Long-term outcomes and comparisons with open surgery for various aortic diseases require further investigation.
Area of Science:
- Cardiovascular Surgery
- Medical Technology
- Vascular Interventions
Background:
- Thoracic endovascular aortic repair (TEVAR) has evolved significantly since its inception in 1987.
- This minimally invasive technique is increasingly utilized for managing thoracic aortic diseases.
- TEVAR presents distinct advantages, particularly in acute thoracic syndromes.
Purpose of the Study:
- To review the current applications of TEVAR in treating thoracic aortic pathologies.
- To discuss the ongoing development and future potential of TEVAR.
- To highlight the remaining uncertainties regarding long-term outcomes and comparisons with traditional treatments.
Main Methods:
- Literature review of TEVAR applications.
- Discussion of technological advancements in TEVAR devices.
- Analysis of clinical outcomes and comparative effectiveness.
Main Results:
- TEVAR is employed for aortic dissection, thoracic aortic aneurysms, penetrating aortic ulcers, and trauma.
- Technological progress continues to expand the scope of TEVAR.
- Comparative data on long-term efficacy against open repair and conservative management are still emerging.
Conclusions:
- TEVAR is a rapidly advancing field with established roles in acute thoracic aortic conditions.
- Further research is essential to fully elucidate the long-term benefits and risks of TEVAR.
- Understanding the comparative advantages against open surgery and conservative care is crucial for optimal patient selection.
Related Concept Videos
Thoracic Aorta
2.5K
The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
2.5K
Aneurysm III: Interprofessional Care
463
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
463
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
580
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
580

